Investor Relations Investors Corporate Profile Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. Copyright West LLC. Minimum 15 minutes delayed. PRESS RELEASES 2/20/20 Alexion to Present at the 9th Annual SVB Leerink Global Healthcare Conference 1/30/20 Alexion Reports Fourth Quarter and Full Year 2019 Results SEE MORE EVENTS & PRESENTATIONS 02/25/20 at 9:30 AM EST Alexion To Present at 9th Annual SVB Leerink Healthcare Conference Listen to Webcast 01/30/20 at 7:30 AM EST Alexion Pharmaceuticals, Inc. Fourth Quarter 2019 Results Listen to Webcast SEE MORE